AG-120, an Oral, Selective, First-in-Class, Potent Inhibitor of Mutant IDH1, Reduces Intracellular 2HG and Induces Cellular Differentiation in TF-1 R132H Cells and Primary Human IDH1 Mutant AML Patient Samples Treated Ex Vivo
暂无分享,去创建一个
Hua Yang | K. Yen | O. Bernard | V. Penard-Lacronique | M. David | A. Fathi | S. Agresta | M. Dorsch | C. Quivoron | J. Micol | H. Sadrzadeh | K. Straley | V. Saada | S. Botton | Janeta Popovici-Muller | Erica Hansen | M. LemieuxRene | C. Gliser | Michael Su | Camelia Gliser